Page results
-
The comprehensive review, co-authored by UCLH Director of Research Prof Bryan Williams, recommends approaches including mindfulness practices and reducing exposure to air polluion.
-
This page explains what you can expect before, during and after your treatment in chemotherapy daycare.
-
This information has been developed by the welfare and benefits team based in the Macmillan Support and Information Service. It outlines the most common benefits available.
-
Help during pregnancy and after having a baby Having a baby can be wonderful – but for as many as 1 in every 5 women it can also be a time of…
-
The following information should be read by organisations referring patients to the UCLH. This is to notify you that University College London Hospitals NHS Foundation Trust (UCLH) intends to…
-
Requests for information should be made in writing. Telephone requests cannot be accepted, except in very exceptional circumstances. We accept requests via email or letter. Freedom of…
-
Health and wellbeing information for people affected by cancer.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
This page is for young people with type 1 diabetes, under the children and young people’s diabetes service at UCLH.
-
We do not accept self-referrals into the adult hearing aid service. All new patients must be either referred by their GP or referred from another UCLH service. When contacting the department to…
File results
-
FOI/2022/0391 - Research into Covid-19 loss of smell and taste
-
FOI/2022/0405 - Treatments C1-esterase inhibitor & immunoglobulin treatments
-
FOI/2022/0407 - Rooftop and greenfield mobile mast site agreements
-
FOI/2022/0411 - Resident Medical Officers/ Resident Doctors/ Senior House Officers supplied by agencies
-
FOI/2022/0421 - Paediatric autoimmune neuropsychiatric disorders
-
FOI/2022/0422 - Annual salary directors
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0465 - Treatment of dermatological conditions
-
FOI/2022/0470 - Total spend on agency staff
-
FOI/2022/0485 - ACR laboratory device